The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Hologic Inc

Nasdaq: HOLX
Last

(U.S.) $38.27

Today's change-0.54 -1.39%
Updated September 1 10:46 AM EDT. Delayed by at least 15 minutes.
 

Hologic Inc

Nasdaq: HOLX
Last

(U.S.) $38.27

Today's change-0.54 -1.39%
Updated September 1 10:46 AM EDT. Delayed by at least 15 minutes.

Hologic Inc down (U.S.)$0.54

Hologic Inc is lower today, dropping (U.S.)$0.54 or 1.39% to (U.S.)$38.27. Over the last five days, shares have gained 0.71% and 43.12% year to date. Shares have outperformed the S&P 500 by 57.48% during the last year.

Key company metrics

  • Open(U.S.) $38.28
  • Previous close(U.S.) $38.81
  • High(U.S.) $38.48
  • Low(U.S.) $38.03
  • Bid / Ask(U.S.) $38.27 / (U.S.) $38.29
  • YTD % change+43.12%
  • Volume334,631
  • Average volume (10-day)3,147,220
  • Average volume (1-month)3,919,488
  • Average volume (3-month)3,142,666
  • 52-week range(U.S.) $22.70 to (U.S.) $43.00
  • Beta1.26
  • Trailing P/E82.17×
  • P/E 1 year forward23.34×
  • Forward PEG2.74×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.47
Updated September 1 10:46 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+5.05%

Based on its net profit margin of 5.05%, Hologic Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.50%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 27, 201506/27/2015Mar 28, 201503/28/2015Dec 27, 201412/27/2014Sep 27, 201409/27/2014
Revenue694656653661
Total other revenue--------
Total revenue694656653661
Gross profit379336339345
Total cost of revenue315320314316
Total operating expense596546556569
Selling / general / administrative167143147152
Research & development56535252
Depreciation / amortization27282829
Interest expense (income), net operating--------
Unusual expense (income)3021520
Other operating expenses, total------0
Operating income981109792
Interest income (expense), net non-operating-52-49-53-53
Gain (loss) on sale of assets--------
Other--------
Income before tax47614439
Income after tax29482928
Income tax, total17131511
Net income29482928
Total adjustments to net income--------
Net income before extra. items29482928
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items29482928
Inc. avail. to common incl. extra. items29482928
Diluted net income29482928
Dilution adjustment------0
Diluted weighted average shares293288283282
Diluted EPS excluding extraordinary itemsvalue per share0.100.170.100.10
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.170.170.140.04